The use of oligonucleotides for gene ampliation, as diagnostic probes or antisense-based drugs can be optimized by minimizing the possibility of nonspecific hybridization.
References
Bernstam, V. A. in Handbook of Gene Level Diagnostics in Clinical Practice 161–630 (CRC Press, Florida, 1992).
Mitsuhashi, M. et al. Nature 357, 519–520 (1992).
Saiki, R. K. et al. Science 230, 1350–1354 (1985).
Wu, D. Y. & Wallace, R. B. Gene 76, 245–254 (1989).
Reynolds, T. J. natn. Cancer Inst. 84, 288–290 (1992).
Mitsuhashi, M. & Hosokawa, T. Nippon Rinsho 52, 530–541 (1994).
March, C. J. et al. Nature 315, 641–647 (1985).
Iizuka, N., Kuge, S. & Nomoto, A. Virology 156, 64–73 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitsuhashi, M., Cooper, A., Ogura, M. et al. Oligonucleotide probe design — a new approach. Nature 367, 759–761 (1994). https://doi.org/10.1038/367759a0
Issue Date:
DOI: https://doi.org/10.1038/367759a0
- Springer Nature Limited
This article is cited by
-
Ex Vivo Induction of mRNA in Human Whole Blood as a New Platform of Drug and Dietary Supplement Development
Pharmaceutical Research (2008)
-
Strategy for designing specific antisense oligonucleotide sequences
Journal of Gastroenterology (1997)